Rusch V - Search Results

1

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers.

Chaft JE, Rusch V, Ginsberg MS, Paik PK, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA. Chaft JE, et al. Among authors: rusch v. J Thorac Oncol. 2013 Aug;8(8):1084-90. doi: 10.1097/JTO.0b013e31829923ec. J Thorac Oncol. 2013. PMID: 23857398 Free PMC article. Clinical Trial.

2

A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results.

Bains MS, Stojadinovic A, Minsky B, Rusch V, Turnbull A, Korst R, Ginsberg R, Kelsen DP, Ilson DH. Bains MS, et al. Among authors: rusch v. J Thorac Cardiovasc Surg. 2002 Aug;124(2):270-7. doi: 10.1067/mtc.2002.122545. J Thorac Cardiovasc Surg. 2002. PMID: 12167786 Free article. Clinical Trial.

3

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, Koong H, Gollub M, Minsky BD, Zakowski M, Turnbull A, Larson SM, Rusch V. Downey RJ, et al. Among authors: rusch v. J Clin Oncol. 2003 Feb 1;21(3):428-32. doi: 10.1200/JCO.2003.04.013. J Clin Oncol. 2003. PMID: 12560430 Clinical Trial.

4

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.

Ilson DH, Bains M, Kelsen DP, O'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD. Ilson DH, et al. Among authors: rusch v. J Clin Oncol. 2003 Aug 1;21(15):2926-32. doi: 10.1200/JCO.2003.02.147. J Clin Oncol. 2003. PMID: 12885811 Clinical Trial.

5

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Miller VA, et al. Among authors: rusch v. J Clin Oncol. 2004 Mar 15;22(6):1103-9. doi: 10.1200/JCO.2004.08.158. J Clin Oncol. 2004. PMID: 15020612

6

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V. Downey RJ, et al. Among authors: rusch v. J Clin Oncol. 2004 Aug 15;22(16):3255-60. doi: 10.1200/JCO.2004.11.109. J Clin Oncol. 2004. PMID: 15310769

7

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H. Pao W, et al. Among authors: rusch v. Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11. doi: 10.1073/pnas.0405220101. Epub 2004 Aug 25. Proc Natl Acad Sci U S A. 2004. PMID: 15329413 Free PMC article.

8

Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.

Rosenzweig KE, Fox JL, Yorke E, Amols H, Jackson A, Rusch V, Kris MG, Ling CC, Leibel SA. Rosenzweig KE, et al. Among authors: rusch v. Cancer. 2005 May 15;103(10):2118-27. doi: 10.1002/cncr.21007. Cancer. 2005. PMID: 15830346 Free article. Clinical Trial.

9

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.

Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, Rusch V. Rizk N, et al. Among authors: rusch v. Ann Thorac Surg. 2006 Mar;81(3):1076-81. doi: 10.1016/j.athoracsur.2005.09.063. Ann Thorac Surg. 2006. PMID: 16488726

10

Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.

López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. López-Ríos F, et al. Among authors: rusch v. Cancer Res. 2006 Mar 15;66(6):2970-9. doi: 10.1158/0008-5472.CAN-05-3907. Cancer Res. 2006. PMID: 16540645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters